LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_032043.3:c.2593C>T
BRIP1
· NP_114432.2:p.(Arg865Trp)
· NM_032043.3
GRCh37: chr17:59763509 G>A
·
GRCh38: chr17:61686148 G>A
Gene:
BRIP1
Transcript:
NM_032043.3
Final call
VUS
PM2 supporting
PP3 moderate
Variant details
Gene
BRIP1
Transcript
NM_032043.3
Protein
NP_114432.2:p.(Arg865Trp)
gnomAD AF
2.6642411745462117e-05 (v4.1)
ClinVar
Uncertain significance
OncoKB
Likely Oncogenic
Classification rationale
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): variant is present but extremely rare in gnomAD (v4.1 total allele frequency 2.66e-05), below the 0.1% rarity threshold.
2
PP3 (Moderate): REVEL score 0.804 falls within the ClinGen-calibrated Pathogenic Moderate band (>=0.773).
3
PM2 (supporting) plus PP3 (moderate) satisfies no generic ACMG/AMP 2015 combining rule, so the variant is classified as VUS.
Final determination:
Generic ACMG/AMP 2015 fallback combining rules require thresholds like (1 PS+1 PM), (3 PM), (2 PS) etc. for LP/P and (1 BS+1 BP)/(2 BP) for LB; 1 PM2-supporting + 1 PP3-moderate meets none, so VUS.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: this missense substitution triggers no null-variant mechanism such as nonsense-mediated decay. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PS1 | Not assessed | Not assessed: no alternate nucleotide change producing the identical p.Arg865Trp change with an established pathogenic classification was available. |
|
| PS2 | Not assessed | Not assessed: no proband phenotype, parental genotypes, or parentage confirmation were available for this variant. |
clinvar
PMID:25741868
|
| PS3 | Not assessed | Not assessed: no validated functional assay data on this variant were found in any cited publication. |
|
| PS4 | Not assessed | Not assessed: no case-control dataset reported carrier counts for this variant in affected individuals versus controls. |
clinvar
|
| PM1 | Not met | Not met: Cancerhotspots.org returned no statistically significant hotspot at residue 865. |
PMID:31822495
|
| PM2 | Met | Met (supporting): gnomAD v4.1 total allele frequency is 2.66e-05 (43/1,613,968), below the 0.1% PM2 threshold. |
gnomad_v4
gnomad_v2
gnomad_canada
|
| PM3 | Not assessed | Not assessed: no affected individual carrying this variant together with a second pathogenic BRIP1 allele was reported. |
clinvar
|
| PM4 | N/A | Not applicable: missense substitution produces no change in protein length. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| PM5 | Not assessed | Not assessed: no alternate missense change at codon 865 with an established pathogenic classification was identified. |
|
| PM6 | Not assessed | Not assessed: no report of this variant arising de novo in a proband with confirmed parental samples was available. |
clinvar
PMID:25741868
|
| PP1 | Not assessed | Not assessed: no evaluable family segregation data were available. |
clinvar
|
| PP2 | Not assessed | Not assessed: missense is a recognized BRIP1 disease mechanism, but no missense constraint metric was available. |
PMID:31822495
|
| PP3 | Met | Met (moderate): REVEL score 0.804 falls in the ClinGen-calibrated Pathogenic Moderate band (>=0.773). |
revel
|
| PP4 | Not assessed | Not assessed: no proband phenotype data demonstrating specificity for a BRIP1-related disorder were available. |
|
| PP5 | Not met | Not met: the ClinVar record lacks expert-panel submissions and is classified as uncertain significance by laboratory submitters. |
clinvar
|
| BA1 | Not met | Not met: highest gnomAD v4.1 population allele frequency is 3.29e-05, far below the 5% BA1 threshold. |
gnomad_v4
gnomad_v2
|
| BS1 | Not met | Not met: gnomAD allele frequencies (maximum 3.29e-05) are below the 0.3% BS1 threshold. |
gnomad_v4
gnomad_v2
|
| BS2 | Not assessed | Not assessed: no phenotype- and age-ascertained observations of this variant in healthy adults were available. |
gnomad_v4
gnomad_v2
|
| BS3 | Not assessed | Not assessed: no functional assay evidence of normal protein activity for this variant was found. |
|
| BS4 | Not assessed | Not assessed: the reported lack of co-segregation in one family was insufficiently documented to establish non-segregation. |
clinvar
|
| BP1 | Not met | Not met: BRIP1 missense variants are an established disease mechanism, so missense cannot be presumed benign. |
PMID:31822495
|
| BP2 | Not assessed | Not assessed: no observation placed this variant in cis or trans with a pathogenic allele. |
clinvar
|
| BP3 | N/A | Not applicable: this is a missense substitution, not an in-frame indel in a repetitive region. |
pvs1_generic_framework
generic_acmg_combination_rules
|
| BP4 | Not met | Not met: REVEL 0.804 falls in the pathogenic direction, so no benign in-silico evidence applies. |
revel
spliceai
|
| BP5 | Not assessed | Not assessed: no data established that the phenotype is explained by an alternative molecular diagnosis. |
|
| BP6 | Not met | Not met: the ClinVar record has no expert-panel Benign/Likely benign assertion. |
clinvar
|
| BP7 | N/A | Not applicable: this is a missense substitution, not a synonymous variant. |
generic_acmg_combination_rules
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.